India has the world's largest diabetic population โ 101 million diagnosed, 136 million pre-diabetic. Most don't know. Most aren't treated. The cost is limbs, kidneys, and lives.
Audio version coming soon
India's diabetes burden has reached a tipping point. The ICMR-INDIAB study published in The Lancet in June 2023 confirmed 101 million diagnosed diabetics, the world's highest absolute count, with another 136 million people in a pre-diabetic state. Only about 25 percent of diagnosed diabetics receive adequate treatment, and the average age of onset has fallen from 45 to roughly 35 years over two decades. Cities show around 14.5 percent prevalence versus 8.5 percent in rural areas, but rural cases are climbing three times faster as diets shift and farm work mechanises. The survey sampled 113,043 people across every Indian state, and Type 2 diabetes accounts for 98 percent of cases. The disease is no longer a problem of the rich elderly. It is now an everyday threat to working-age Indians across class and geography.
Three structural shifts converged over thirty years to create this crisis. First, refined carbohydrates replaced coarse grains like millet and sorghum as everyday staples. White rice and wheat-based bread now dominate diets that evolved over centuries around finger millet and barley, roughly doubling the glycemic load of an average Indian meal since 1990. Second, India urbanised at thirty million people per year for two decades, and former farm labourers became auto drivers and office workers. WHO data shows only 18 percent of Indian adults meet recommended physical activity levels. Third, South Asians carry a genetic susceptibility to insulin resistance at lower BMI, with higher visceral fat and lower muscle mass per kilogram of body weight. An Indian at BMI 23 has diabetes risk equivalent to a European at BMI 28, which is why standard BMI cutoffs miss most early Indian cases entirely.
Disease burden and complications across India today:
Unread picks stay on top. Fresh stories may appear as they are ready โ no extra loading.
UnreadIndia now has 12 million obese children under 19, according to ICMR data. School canteens sell junk food while ultra-processed food advertising targets children.
UnreadIndia collects only 11 million units of blood annually against a need of 15 million. The O-negative shortage is acute, urban blood banks run on single-day reserves, and the rural gap is catastrophic.
UnreadIndia has fewer sports medicine doctors than many US college programs. Cricket and marathons grew fast; specialist care did not, so preventable injuries end careers early.
UnreadBiosimilars โ cheaper copies of complex biological drugs โ are worth 50 billion globally. Indian companies are racing to capture that market, threatening to cut the price of cancer and.
UnreadMicronutrient gaps hit rich and poor: anaemia stays high, vegetarians often lack B12, and urban adults lack vitamin D. Fortification and better diets can bend the curve if delivery improves.
Unread127 essential medicines are out of stock in government hospitals across 12 states. The shortage hits insulin, antibiotics and cancer drugs. Central procurement failure exposes PM Jan Aushadhi gaps.
Myth 1: Only fat people get diabetes. Fact: India's thin-fat phenotype means 40 percent of Indian diabetics have a normal BMI by international standards. Visceral fat stored around organs accumulates in Indians at lower body weight. A normal-weight Indian with a waist above 90 cm for men or 80 cm for women is already at high risk.
Myth 2: Once you start insulin, you are dependent on it forever. Fact: This belief is the single biggest barrier to insulin initiation in India. Insulin resistance is the disease and insulin is one treatment, not an addiction. Many Type 2 patients started on insulin during a crisis are later managed on oral drugs once glucose toxicity reverses. Fear of insulin delays treatment until severe complications arrive.
Myth 3: Ayurvedic herbs can cure diabetes. Fact: Bitter gourd, fenugreek and jamun have modest evidence for mildly lowering post-meal glucose, not for curing the disease. ICMR has approved no traditional cure. Replacing metformin or insulin with herbs causes preventable amputations, blindness and kidney failure every year in rural India.
Take Sushila Yadav, a 42-year-old domestic worker from Patna who was diagnosed only when her wound refused to heal after a kitchen burn. Her family now spends 18,000 rupees per year on metformin, insulin and strips, which is nearly a fifth of their household income. A typical Indian diabetic family spends between 12,000 and 20,000 rupees yearly on drugs and monitoring alone. A single hospital admission for an amputation or dialysis initiation costs 80,000 to 3 lakh rupees, enough to push a lower-middle-class family into debt. Rural women are diagnosed on average six years later than urban men because they reach a doctor last. A 2022 Lancet Regional study found 62 percent of rural diabetic women were diagnosed only when hospitalised with a complication. Diabetes diagnosed at 35 means three decades of expensive care during peak earning years, and NIMHANS researchers link younger diabetic men to triple the depression rate of their peers.
The deeper lesson is that India's diabetes epidemic is not just a health story, it is a development story. The disease taxes the same families who can least afford it, drains productive workers during their peak earning years, and quietly hollows out the household savings that fuel small-business India. If current trends continue, the country will be managing 150 million diabetics by 2030 and the long-term impact on GDP, hospital capacity and family stability will be enormous. The good news is that the tools to slow this exist. Generic metformin costs five rupees a day, ICMR's screening models can identify millions of undiagnosed cases through a 90-second questionnaire at Health and Wellness Centres, and millet on the public distribution system would cut glycemic load for the poorest. The future depends on whether the state treats diabetes as a chronic care problem to be managed early, rather than a complication to be admitted late.
Chronology
Follow the arc from background to turning points. On mobile, swipe the cards and use the step rail below; on desktop, use the spine to jump.
Indian medical textbooks of the 1970s classified diabetes as a disease of affluence with estimated prevalence under 1.5 percent nationally. Rural India was considered essentially unaffected.
Dr Vijay Mohan's Chennai Urban Rural Epidemiology Study finds urban Tamil Nadu diabetes prevalence at 11.6 percent, far above WHO estimates, and the Indian epidemic becomes visible.
With 31.7 million diagnosed diabetics, India surpasses China. The designation generates media attention but limited policy response.
Government launches NP-NCD to screen for diabetes and hypertension at primary health centres, but rollout is slow and less than 30 percent of PHCs implement it by 2015.
PM-JAY covers hospitalisation for diabetic complications. Routine drug supply and outpatient management remain uncovered, incentivising late-stage intervention over prevention.
The Lancet publishes India's first nationally representative diabetes survey. Data from 113,043 individuals across all 31 states confirms 101 million diabetics and 136 million pre-diabetics.
Government rolls out millet supply through the public distribution system in select districts to cut glycemic load in poor households, but coverage stays under 5 percent of beneficiaries.
Step 1/7 events
Understand why it happened, how we got here, and what might come next.